Alvotech (ALVO) Accumulated Expenses (2021)
Alvotech (ALVO) posted Accumulated Expenses of $4785.0 for Q4 2021.
Alvotech (ALVO) Accumulated Expenses (2021) Analysis & Trends
Alvotech's Accumulated Expenses history runs 1 years deep, the most recent figure standing at $4785.0 for Q4 2021.
- Quarterly Accumulated Expenses changed N/A year-over-year to $4785.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $4785.0 (changed N/A YoY) and the FY2021 annual result came in at $4785.0, changed N/A from the prior year.
- Accumulated Expenses was $4785.0 for Q4 2021 at Alvotech.
- Across five years, Accumulated Expenses topped out at $4785.0 in Q4 2021 and bottomed at $4785.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4,785.00 |